TrademarkOpen
Search / United States / 90842314

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

CLEARIFY

Registered
Used for: Human allograft tissue

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 26 Jul 2021
    Application filed
    New Application Entered
  2. 18 Apr 2022
    Assigned to an examining attorney
    Assigned To Examiner
  3. 19 Apr 2022
    Office action issued
    Non-Final Action Written
  4. 18 Oct 2022
    Response to office action filed
    Teas Response To Office Action Received
  5. 10 Dec 2022
    Approved for publication
    Approved For Pub - Principal Register
  6. 17 Jan 2023
    Published for opposition
    Published For Opposition
  7. 14 Mar 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 5 Jun 2023
    Statement of use filed
    Teas Statement Of Use Received
  9. 30 Jun 2023
    Office action issued
    Non-Final Action Written
  10. 10 Jul 2023
    Response to office action filed
    Teas Response To Office Action Received
  11. 14 Jul 2023
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  12. 15 Jul 2023
    Statement of use accepted
    Notice Of Acceptance Of Statement Of Use E-Mailed
  13. 22 Aug 2023
    Registered on the Principal Register
    Registered-Principal Register
All 29 events
2023-08-22Registered-Principal Register
2023-08-22Notice Of Registration Confirmation Emailed
2023-07-15Notice Of Acceptance Of Statement Of Use E-Mailed
2023-07-14Allowed Principal Register - Sou Accepted
2023-07-11Teas/Email Correspondence Entered
2023-07-10Teas Response To Office Action Received
2023-07-10Correspondence Received In Law Office
2023-06-30Non-Final Action Written
2023-06-30Non-Final Action E-Mailed
2023-06-30Notification Of Non-Final Action E-Mailed
2023-06-29Case Assigned To Intent To Use Paralegal
2023-06-29Statement Of Use Processing Complete
2023-06-05Teas Statement Of Use Received
2023-06-05Use Amendment Filed
2023-03-14Noa Mailed - Sou Required From Applicant
2023-01-17Published For Opposition
2023-01-17Official Gazette Publication Confirmation E-Mailed
2022-12-28Notification Of Notice Of Publication E-Mailed
2022-12-10Approved For Pub - Principal Register
2022-12-09Assigned To Lie
2022-12-09Correspondence Received In Law Office
2022-12-09Teas/Email Correspondence Entered
2022-10-18Teas Response To Office Action Received
2022-04-19Non-Final Action Written
2022-04-19Non-Final Action E-Mailed
2022-04-19Notification Of Non-Final Action E-Mailed
2022-04-18Assigned To Examiner
2021-09-22New Application Office Supplied Data Entered
2021-07-26New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Human allograft tissue

First use anywhere 23 Sep 2022 · First use in commerce 23 Sep 2022

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 26 Aug 2023; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.